AGIOS PHARMACEUTICALS, INC.: operating_income

Value{"amount": -425737000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2024-01-01 – 2024-12-31
Statuscurrent
EntityAGIOS PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001439222-25-000009
Retrieved: 2026-08-19T14:11:29.585785+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001439222/operating-income/2024-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/792f80b6-6355-4dde-84ba-cf797031c094

History